Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
41.37
-2.28 (-5.22%)
At close: Nov 20, 2026, 4:00 PM EST
41.40
+0.03 (0.07%)
After-hours: Nov 20, 2026, 7:30 PM EST
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $5.85 billion as of November 20, 2026. It is the 3,043rd most valuable company in the world and the 1,006th biggest in the United States. Its market cap has increased by 8.55% in one year.
Market Cap
5.85B
Enterprise Value
6.07B
1-Year Change
8.55%
Global Rank
Country Rank
#1,006 United States
Category
ChartMarket Cap Chart
Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $5.85B, an increase of 1,949,364.78%. That is a compound annual growth rate of 54.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 5.85B | -35.14% |
| Dec 31, 2025 | 9.02B | 285.42% |
| Dec 31, 2024 | 2.34B | -28.84% |
| Dec 29, 2023 | 3.29B | -23.54% |
| Dec 30, 2022 | 4.30B | -37.84% |
| Dec 31, 2021 | 6.92B | -11.95% |
| Dec 31, 2020 | 7.86B | 29.67% |
| Dec 31, 2019 | 6.06B | 451.13% |
| Dec 31, 2018 | 1.10B | 299.42% |
| Dec 29, 2017 | 275.20M | 154.58% |
| Dec 30, 2016 | 108.10M | -70.48% |
| Dec 31, 2015 | 366.20M | -9.27% |
| Dec 31, 2014 | 403.60M | -3.88% |
| Dec 31, 2013 | 419.90M | 1,153.43% |
| Dec 31, 2012 | 33.50M | -24.04% |
| Dec 30, 2011 | 44.10M | -31.42% |
| Dec 31, 2010 | 64.30M | 93.09% |
| Dec 31, 2009 | 33.30M | -15.70% |
| Dec 31, 2008 | 39.50M | -72.93% |
| Dec 31, 2007 | 145.90M | -2.60% |
| Dec 29, 2006 | 149.80M | 25.99% |
| Dec 30, 2005 | 118.90M | 101.87% |
| Dec 31, 2004 | 58.90M | 19,533.33% |
| Jan 15, 2004 | 300.00K | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 7.14B |
| Corcept Therapeutics | 7.11B |
| ABIVAX Société Anonyme | 7.05B |
| ImmunityBio | 6.99B |
| Immunovant | 6.73B |
| Oruka Therapeutics | 6.62B |
| Kodiak Sciences | 6.39B |
| Mirum Pharmaceuticals | 6.24B |